Infracore SA announces final IPO size at the fixed price of CHF 54 per share and beginning of trading on SIX Swiss Exchange tomorrow

FOR RELEASE IN SWITZERLAND – THIS IS A RESTRICTED COMMUNICATION AND YOU MUST NOT FORWARD IT OR ITS CONTENTS TO ANY PERSON TO WHOM FORWARDING THIS COMMUNICATION IS PROHIBITED. NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL OR REQUIRE REGISTRATION OR ANY OTHER MEASURES.
This press release contains information about Medical Properties Trust Inc. (“MPT”). Any information relating to MPT herein is derived solely from MPT’s public filings with the US Securities and Exchange Commission (“SEC”). Investors should refer exclusively to such SEC filings for information concerning MPT. MPT has not (a) participated in the preparation of this press release or (b) endorsed the views expressed herein. MPT HAS NOT ENDORSED THE VIEWS EXPRESSED HEREIN OR PROVIDED ANY REPRESENTATION OR WARRANTY (EXPRESS OR IMPLIED) AS TO THE ACCURACY OF ANY INFORMATION PROVIDED HEREIN. NOTHING IN THIS PRESS RELEASE SHALL CONSTITUTE OR BE INTERPRETED AS AN OFFER OR SOLICITATION TO PURCHASE MPT'S SECURITIES IN ANY JURISDICTION.

Press release
Fribourg, 8 July 2026

Infracore SA announces final IPO size at the fixed price of CHF 54 per share and beginning of trading on SIX Swiss Exchange tomorrow

Infracore SA (“Infracore” or the “Company”), a Swiss real estate company specialized in hospital and healthcare infrastructure, today announces the final size of its initial public offering on SIX Swiss Exchange (the “IPO” or the “Offering”) at the fixed offer price previously announced of CHF 54.00 per share. The Company's registered shares will be listed and start trading under the ticker symbol “INFRAC” on SIX Swiss Exchange tomorrow, 9 July 2026.

• The Offering consists of 3,703,703 newly issued registered shares and 505,500 existing registered shares offered by the Company's largest shareholder, MPT Switzerland Holdings
  S.à r.l. (“MPT”), a subsidiary of Medical Properties Trust, Inc., through the partial exercise of an upsize option based on the interest of Swiss and international investors (the “Base Offer”), with an over-allotment option of up to 420,920 existing registered shares offered by MPT (up to 10% of the Base Offer).
• Based on the fixed offer price of CHF 54 per share and the offer size, the market capitalization of Infracore at listing will be CHF 826 million.
• Infracore's shares will be listed and start trading under the ticker symbol “INFRAC” on SIX Swiss Exchange tomorrow, 9 July 2026 (9:00 CEST) with settlement of the IPO expected to occur on 10 July 2026.
• Infracore is expected to be included in the Swiss Performance Index (“SPI”), the SPI Extra, and the real estate index SXI Real Estate Shares Broad (REAL) on its second trading day, i.e. 10 July 2026.

During the IPO process, the syndicate banks successfully placed 3,703,703 newly issued registered shares as well as 505,500 existing registered shares offered by MPT, each at the offer price of CHF 54 per share. Furthermore, MPT has granted a customary secondary over-allotment option of up to 420,920 existing registered shares, exercisable at the offer price in whole or in part within 30 calendar days following the first day of trading. This implies a total placement volume of up to CHF 250 million. Based on the fixed offer price of CHF 54 per share, Infracore's market capitalization is CHF 826 million.

Infracore is raising gross proceeds of approximately CHF 200 million through the issuance of the new shares. The Company intends to use the primary proceeds mainly to finance its sale-and-leaseback pipeline, to finance its development pipeline and to establish a capital structure that supports its growth strategy, as well as to repay shareholder loans of approximately CHF 55.2 million.

Infracore’s shares will be traded as of tomorrow, 9 July 2026, 09:00 CEST on SIX Swiss Exchange under the ticker symbol INFRAC. Infracore is expected to be included in the Swiss Performance Index (“SPI”), the SPI Extra, and the real estate index SXI Real Estate Shares Broad (REAL) on its second trading day, i.e. 10 July 2026.

Eric Frey, CEO of Infracore, says: “Today marks an important milestone for Infracore. The strong interest from investors confirms the attractiveness of our business model and growth prospects. With a portfolio of high-quality healthcare real estate and a strong market position in Switzerland, we are well-placed to continue executing our growth strategy and creating long-term value.”

Free float

Based on the Base Offer size of 4,209,203 registered shares (i.e. with the partial exercise of the upsize option but without exercise of the over-allotment option), the free float will be of 27.5%. AEVIS VICTORIA SA (“AEVIS”) and MPT are expected to hold 22.6% and 49.9% of the shares, respectively, on a pro forma basis after completion of the IPO (down from the respective pre-IPO ownerships of 30% and 70%, respectively). In case of full exercise of the over-allotment option, the free float will increase accordingly up to a maximum of approximately 30.3% and MPT's pro forma ownership will approximate 47.1%.

Current shareholders and lock-up undertakings

The current main shareholders MPT and AEVIS will remain significant shareholders of Infracore after completion of the IPO. AEVIS intends to retain its entire shareholding in Infracore and to support the Company in its next phase of development. In connection with the IPO, the Company, MPT and AEVIS have agreed to a lock-up period of 180 days from the first day of trading vis-à-vis the Joint Global Coordinators. Each lock-up undertaking is subject to customary exceptions and waiver by the Joint Global Coordinators. For the duration of the lock-up, i.e. until 5 January 2027, AEVIS and MPT will thus form a group of shareholders for purposes of the Swiss disclosure rules and regulations.

Citi and Zürcher Kantonalbank acted as Joint Global Coordinators and Joint Bookrunners of the IPO. Baader Bank acted as Joint Bookrunner, Swiss Finance & Property AG as Co-Manager and Octavian as Selling Agent. Rothschild & Co served as financial advisor to AEVIS.

Key IPO information and indicative IPO timetable

Key IPO information   Listing SIX Swiss Exchange (Standard for Real Estate Companies) Ticker symbol INFRAC Swiss security number 1986768 ISIN CH0019867685 Nominal value CHF 1.00 per registered share Offer price CHF 54.00 per share (fixed price) Base Offer size Base offering of 4,209,203 shares (3,703,703 newly issued shares and 505,500 existing shares) Over-allotment option Up to 420,920 existing registered shares (10% of base offering) Indicative IPO timetable   Listing and first trading day 9 July 2026 Delivery of offered shares against payment of the offer price and settlement 10 July 2026 Last day to exercise the over-allotment option
  7 August 2026

 

 

About Infracore SA

Infracore SA is one of Switzerland’s leading owners of healthcare infrastructure. The company owns and develops a real estate portfolio dedicated to the healthcare sector. Its model is based on long-term lease agreements with hospital and healthcare operators, providing high visibility of rental income and direct exposure to the growing need for modern healthcare infrastructure in Switzerland. On 30 June 2026, Infracore SA announced the launch of its initial public offering, with its shares to be listed on SIX Swiss Exchange on or around 9 July 2026. www.infracore.ch

About Medical Properties Trust, Inc.

Medical Properties Trust, Inc. is a self-advised real estate investment trust formed in 2003 to acquire and develop net-leased hospital facilities. From its inception in Birmingham, Alabama, the Company has grown to become one of the world’s largest owners of hospital real estate with 378 facilities and approximately 38,000 licensed beds in nine countries and across three continents as of March 31, 2026. MPT’s financing model facilitates acquisitions and recapitalizations, and allows operators of hospitals to unlock the value of their real estate assets to fund facility improvements, technology upgrades and other investments in operations. www.mpt.com

About AEVIS VICTORIA SA

AEVIS VICTORIA SA invests in healthcare, hospitality & lifestyle and infrastructure. AEVIS′s main shareholdings are Swiss Medical Network Holding SA (76.3%, directly and indirectly), the only Swiss private network of hospitals present in the country’s three main language regions, MRH Switzerland AG, a luxury hotel group managing eleven hotels in Switzerland and abroad, Infracore SA (30.0%, directly and indirectly), a real estate company dedicated to healthcare-related infrastructure, Swiss Hotel Properties SA, a hospitality real estate division, and NESCENS SA, a brand dedicated to better aging. AEVIS is listed on the Swiss Reporting Standard of the SIX Swiss Exchange (AEVS.SW). www.aevis.com

 

THIS DOCUMENT IS NOT AN OFFER TO SELL OR A SOLICITATION OF OFFERS TO PURCHASE OR SUBSCRIBE FOR SHARES OR OTHER SECURITIES. THIS DOCUMENT IS NOT A PROSPECTUS WITHIN THE MEANING OF THE SWISS FINANCIAL SERVICES ACT AND NOT A PROSPECTUS OR AN OFFERING MEMORANDUM UNDER ANY OTHER APPLICABLE LAWS. COPIES OF THIS DOCUMENT MAY NOT BE SENT TO JURISDICTIONS, OR DISTRIBUTED IN OR SENT FROM JURISDICTIONS, IN WHICH THIS IS BARRED OR PROHIBITED BY LAW. THE INFORMATION CONTAINED HEREIN SHALL NOT CONSTITUTE AN OFFER TO SELL OR THE SOLICITATION OF AN OFFER TO BUY, IN ANY JURISDICTION IN WHICH SUCH OFFER OR SOLICITATION WOULD BE UNLAWFUL PRIOR TO REGISTRATION, EXEMPTION FROM REGISTRATION OR QUALIFICATION UNDER THE SECURITIES LAWS OF ANY JURISDICTION. THE OFFER AND LISTING OF ANY SECURITIES WILL BE MADE SOLELY BY MEANS OF, AND ON THE BASIS OF, A PROSPECTUS OR AN OFFERING MEMORANDUM WHICH IS TO BE APPROVED BY THE COMPETENT REVIEW BODY AND PUBLISHED.

THIS PUBLICATION CONSTITUTES ADVERTISING WITHIN THE MEANING OF ARTICLE 68 OF THE SWISS FINANCIAL SERVICES ACT. SUCH ADVERTISEMENTS ARE COMMUNICATIONS TO INVESTORS AIMING TO DRAW THEIR ATTENTION TO FINANCIAL INSTRUMENTS. ANY INVESTMENT DECISIONS WITH RESPECT TO ANY SECURITIES SHOULD NOT BE MADE BASED ON THIS ADVERTISEMENT. A DECISION TO INVEST IN SECURITIES OF INFRACORE SA ("INFRACORE" OR THE "COMPANY") SHOULD BE BASED EXCLUSIVELY ON THE PROSPECTUS PUBLISHED BY THE COMPANY FOR SUCH PURPOSE. COPIES OF SUCH PROSPECTUS (AND ANY SUPPLEMENTS THERETO) ARE AVAILABLE FREE OF CHARGE FROM ZÜRCHER KANTONALBANK, IHKT, P.O. BOX, 8010 ZURICH, SWITZERLAND (EMAIL: PROSPECTUS@ZKB.CH). IN ADDITION, COPIES OF SUCH PROSPECTUS (AND ANY SUPPLEMENTS THERETO) CAN BE OBTAINED FREE OF CHARGE IN SWITZERLAND FROM INFRACORE SA, INVESTOR RELATIONS, CLINIQUE GENERALE STE-ANNE, RUE HANS-GEILER 6, 1700 FRIBOURG (TELEPHONE: +41 26 350 02 10; EMAIL: INVESTOR@INFRACORE.CH). INVESTORS ARE FURTHERMORE ADVISED TO CONSULT THEIR BANK OR FINANCIAL ADVISER BEFORE MAKING ANY INVESTMENT DECISION.

THIS DOCUMENT IS NOT FOR PUBLICATION OR DISTRIBUTION IN THE UNITED STATES OF AMERICA (INCLUDING ITS TERRITORIES AND POSSESSIONS, ANY STATE OF THE UNITED STATES AND THE DISTRICT OF COLUMBIA) (THE "UNITED STATES" OR THE "U.S."), CANADA, JAPAN OR AUSTRALIA OR ANY OTHER JURISDICTION INTO WHICH THE SAME WOULD BE UNLAWFUL. THIS DOCUMENT DOES NOT CONSTITUTE AN OFFER OR INVITATION TO SUBSCRIBE FOR OR PURCHASE ANY SECURITIES IN SUCH COUNTRIES OR IN ANY OTHER JURISDICTION INTO WHICH THE SAME WOULD BE UNLAWFUL. IN PARTICULAR, THE DOCUMENT AND THE INFORMATION CONTAINED HEREIN SHOULD NOT BE DISTRIBUTED OR OTHERWISE TRANSMITTED INTO THE UNITED STATES OR TO PUBLICATIONS WITH A GENERAL CIRCULATION IN THE UNITED STATES. THE SECURITIES REFERRED TO HEREIN HAVE NOT BEEN AND WILL NOT BE REGISTERED UNDER THE U.S. SECURITIES ACT OF 1933, AS AMENDED (THE "SECURITIES ACT"), OR THE LAWS OF ANY STATE, AND MAY NOT BE OFFERED OR SOLD IN THE UNITED STATES ABSENT REGISTRATION UNDER OR AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT. THERE WILL BE NO PUBLIC OFFERING OF THE SECURITIES IN THE UNITED STATES.

THE INFORMATION CONTAINED HEREIN DOES NOT CONSTITUTE AN OFFER OF SECURITIES TO THE PUBLIC IN THE UNITED KINGDOM. NO PROSPECTUS OFFERING SECURITIES TO THE PUBLIC WILL BE PUBLISHED IN THE UNITED KINGDOM. THIS DOCUMENT IS ONLY BEING DISTRIBUTED TO AND IS ONLY DIRECTED AT PERSONS WHO (I) ARE OUTSIDE THE UNITED KINGDOM OR (II) ARE "QUALIFIED INVESTORS" WITHIN THE MEANING OF PARAGRAPH 15 OF SCHEDULE 1 TO THE UK PUBLIC OFFERS AND ADMISSIONS TO TRADING REGULATIONS 2024 WHO ARE ALSO (A) INVESTMENT PROFESSIONALS FALLING WITHIN ARTICLE 19(5) OF THE FINANCIAL SERVICES AND MARKETS ACT 2000 (FINANCIAL PROMOTION) ORDER 2005, AS AMENDED FROM TIME TO TIME (THE "ORDER"), (B) HIGH NET WORTH ENTITIES FALLING WITHIN ARTICLE 49(2)(A) TO (D) OF THE ORDER, (C) PERSONS WHO ARE CERTIFIED HIGH NET WORTH INDIVIDUALS FALLING WITHIN ARTICLE 48 OF THE ORDER, (D) PERSONS WHO ARE CERTIFIED SOPHISTICATED INVESTORS FALLING WITHIN ARTICLE 50 OF THE ORDER, OR (E) PERSONS WHO ARE SELF-CERTIFIED SOPHISTICATED INVESTORS FALLING WITHIN ARTICLE 50A OF THE ORDER (ALL SUCH PERSONS BEING REFERRED TO AS "RELEVANT PERSONS"). THE SECURITIES ARE ONLY AVAILABLE TO, AND ANY INVITATION, OFFER OR AGREEMENT TO SUBSCRIBE, PURCHASE OR OTHERWISE ACQUIRE SUCH SECURITIES WILL BE ENGAGED IN ONLY WITH, RELEVANT PERSONS. ANY PERSON WHO IS NOT A RELEVANT PERSON SHOULD NOT ACT OR RELY ON THIS DOCUMENT OR ANY OF ITS CONTENTS.

IN ANY MEMBER STATE OF THE EUROPEAN ECONOMIC AREA, THIS DOCUMENT IS ONLY ADDRESSED TO QUALIFIED INVESTORS IN SUCH MEMBER STATE WITHIN THE MEANING OF REGULATION (EU) 2017/1129, AND NO PERSON THAT IS NOT A QUALIFIED INVESTOR MAY ACT OR RELY ON THIS DOCUMENT OR ANY OF ITS CONTENTS.

THIS PUBLICATION MAY CONTAIN SPECIFIC FORWARD-LOOKING STATEMENTS, E.G. STATEMENTS INCLUDING TERMS LIKE "BELIEVE", "ASSUME", "EXPECT", "FORECAST", "PROJECT", "MAY", "COULD", "MIGHT", "WILL" OR SIMILAR EXPRESSIONS. SUCH FORWARD-LOOKING STATEMENTS ARE SUBJECT TO KNOWN AND UNKNOWN RISKS, UNCERTAINTIES AND OTHER FACTORS WHICH MAY RESULT IN A SUBSTANTIAL DIVERGENCE BETWEEN THE ACTUAL RESULTS, FINANCIAL SITUATION, DEVELOPMENT OR PERFORMANCE OF INFRACORE AND THOSE EXPLICITLY OR IMPLICITLY PRESUMED IN THESE STATEMENTS. AGAINST THE BACKGROUND OF THESE UNCERTAINTIES, READERS SHOULD NOT RELY ON FORWARD-LOOKING STATEMENTS. INFRACORE ASSUMES NO RESPONSIBILITY TO UPDATE FORWARD-LOOKING STATEMENTS OR TO ADAPT THEM TO FUTURE EVENTS OR DEVELOPMENTS. EXCEPT AS REQUIRED BY APPLICABLE LAW, INFRACORE HAS NO INTENTION OR OBLIGATION TO UPDATE, KEEP UPDATED OR REVISE THIS PUBLICATION OR ANY PARTS THEREOF FOLLOWING THE DATE HEREOF.

NONE OF THE SELLING SHAREHOLDER, THE MANAGERS OR ANY OF THEIR RESPECTIVE SUBSIDIARY UNDERTAKINGS, AFFILIATES AND CONTROLLING PERSONS OR ANY OF THEIR RESPECTIVE DIRECTORS, OFFICERS, EMPLOYEES, ADVISERS, AGENTS, ALLIANCE PARTNERS OR ANY OTHER ENTITY OR PERSON ACCEPTS ANY RESPONSIBILITY OR LIABILITY WHATSOEVER FOR, OR MAKES ANY REPRESENTATION, WARRANTY OR UNDERTAKING, EXPRESS OR IMPLIED, AS TO THE TRUTH, ACCURACY, COMPLETENESS OR FAIRNESS OF THE INFORMATION OR OPINIONS IN THIS ANNOUNCEMENT (OR WHETHER ANY INFORMATION HAS BEEN OMITTED FROM THE ANNOUNCEMENT) OR ANY OTHER INFORMATION RELATING TO INFRACORE, ITS GROUP, ITS SUBSIDIARIES OR ASSOCIATED COMPANIES, WHETHER WRITTEN, ORAL OR IN A VISUAL OR ELECTRONIC FORM, AND HOWSOEVER TRANSMITTED OR MADE AVAILABLE OR FOR ANY LOSS HOWSOEVER ARISING FROM ANY USE OF THIS ANNOUNCEMENT OR ITS CONTENTS OR OTHERWISE ARISING IN CONNECTION THEREWITH. ACCORDINGLY, EACH OF THE MANAGERS AND THE OTHER FOREGOING PERSONS DISCLAIM, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, ALL AND ANY LIABILITY, WHETHER ARISING IN TORT OR CONTRACT OR THAT THEY MIGHT OTHERWISE BE FOUND TO HAVE IN RESPECT OF THIS ANNOUNCEMENT AND/OR ANY SUCH STATEMENT.